09/02/2026
Dr. Neil Campbell is a faculty member in Duquesne’s Biotechnology program and an accomplished leader in the biotechnology, healthcare and life sciences industries.
With more than 30 years of experience, Dr. Campbell has researched, developed and commercialized more than 275 products and services throughout his career. He has held leadership roles across biotechnology, personalized healthcare, diagnostics, medical devices, artificial intelligence and health technology.
Dr. Campbell currently serves as President and CEO of Humanetix, Inc. and Executive Chairman of Mosaigen and RespaRx. Throughout his career, he has founded and led innovative companies, including Celios, Helomics and SuperNova Diagnostics, and has held senior executive positions with organizations including Roche, Abbott Laboratories, Celera Genomics and Life Technologies.
Bringing decades of real-world industry experience into the classroom, Dr. Campbell helps prepare the next generation of biotechnology professionals to lead, innovate and make an impact. At Duquesne, you’ll learn from faculty who have helped shape the future of science and technology.
Apply to the biotechnology program at duq.edu/biotechnology.